Clinical Trial Update: D-serine Augmentation of Neuroplasticity [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial updates on D-serine augmentation to enhance neuroplasticity in schizophrenia and schizoaffective disorder; study completed with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• D-serine (D-serine)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Schizophrenia, Schizo Affective Disorder | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-06-14